These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


391 related items for PubMed ID: 12469913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW, Pathrose P, Barmina O, Chang CY, McDonnell DP, Yamamoto H, Shevde NK.
    J Cell Biochem; 2003 Feb 01; 88(2):252-8. PubMed ID: 12520523
    [Abstract] [Full Text] [Related]

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 4. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 01; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 6. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.
    Okamura M, Takano Y, Saito Y, Yao J, Kitamura M.
    Nephrol Dial Transplant; 2009 Oct 01; 24(10):3006-12. PubMed ID: 19474283
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR.
    Mol Endocrinol; 1996 Dec 01; 10(12):1617-31. PubMed ID: 8961271
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J, Oberg F, Törmä H, Tuohimaa P, Bläuer M, Nilsson K.
    Cell Growth Differ; 1996 Sep 01; 7(9):1239-49. PubMed ID: 8877104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
    Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S.
    J Immunol; 1998 Jan 01; 160(1):209-18. PubMed ID: 9551973
    [Abstract] [Full Text] [Related]

  • 15. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
    Li J, Finch RA, Sartorelli AC.
    Exp Cell Res; 1999 Jun 15; 249(2):279-90. PubMed ID: 10366427
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
    D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P.
    J Clin Invest; 1998 Jan 01; 101(1):252-62. PubMed ID: 9421488
    [Abstract] [Full Text] [Related]

  • 17. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR.
    Mol Cell Biol; 1993 Sep 01; 13(9):5907-17. PubMed ID: 8395017
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS.
    Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):65-72. PubMed ID: 9723887
    [Abstract] [Full Text] [Related]

  • 19. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
    Solomon C, Macoritto M, Gao XL, White JH, Kremer R.
    J Bone Miner Res; 2001 Jan 25; 16(1):39-45. PubMed ID: 11149488
    [Abstract] [Full Text] [Related]

  • 20. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G, Verlinden L, van Camp M, van Hummelen P, Marchal K, de Moor B, Mathieu C, Carmeliet G, Bouillon R, Verstuyf A.
    J Bone Miner Res; 2004 Jan 25; 19(1):133-46. PubMed ID: 14753745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.